Company Name, Ticker, Suppliers, else..

• Gross Margin

• EBITDA Margin

• Operating Margin

• Pre-Tax Margin

• Effective Tax Rate

• Free Cash Flow Margin

• Cash Flow Margin

Valuation Comparisons

Management Effectiveness

Financial Strength

Dividend Comparisons

Abbvie Inc (NYSE: ABBV)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Abbvie Inc Profitability Comparisons

Select each Category to receive further Information

Select the Comparisons :

Profitability ▼

Select the Ratio:

None▼

Profitability ▼

None▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ABBV Profitability Ratio	Company	Industry	Sector	S&P 500
Gross Profit Margin (Q1 MRQ)	71.88 %	70.91 %	65.43 %	47.43 %
Gross Margin (Q1 TTM)	70.68 %	71.73 %	66.39 %	46.67 %
Gross Profit Margin 5 Yr. Avg.	68.32 %	67.82 %	65.56 %	47.82 %
EBITDA Margin (Q1 MRQ)	24.13 %	22.25 %	19.59 %	21.4 %
EBITDA Margin (Q1 TTM)	26.51 %	25.28 %	20.86 %	19.31 %
EBITDA Margin 5 Yr. Avg.	33.63 %	47.09 %	31.56 %	22.45 %
Operating Margin (Q1 MRQ)	26.6 %	17.27 %	16.57 %	16.73 %
Operating Margin (Q1 TTM)	24.41 %	20.33 %	17.92 %	16.52 %
Operating Margin 5 Yr. Avg.	25.49 %	15.37 %	14.33 %	17.24 %
Pre-Tax Profit Margin (Q1 MRQ)	6.93 %	13.66 %	10.93 %	14.14 %
Pre-Tax Profit Margin (Q1 TTM)	9.51 %	16.7 %	12.86 %	13.13 %
Pre-Tax Profit Margin 5 Yr. Avg.	15.04 %	12.99 %	10.37 %	12.42 %
Net Margin (Q1 MRQ)	4.65 %	10.09 %	8.14 %	11.6 %
Net Margin (Q1 TTM)	5.8 %	13.13 %	9.99 %	10.8 %
Net Margin 5 Yr. Avg.	12.89 %	5.8 %	6.08 %	9.9 %

Business Segment			Profit Margin

All other			-
Immunology Humira			-
Immunology Humira United States			-
Immunology Humira International			-
Immunology Skyrizi			-
Immunology Skyrizi United States			-
Immunology Skyrizi International			-
Immunology Rinvoq			-
Immunology Rinvoq United States			-
Immunology Rinvoq International			-
Aesthetics Botox Cosmetic			-
Aesthetics Botox Cosmetic United States			-
Aesthetics Botox Cosmetic International			-
Aesthetics Juvederm Collection			-
Aesthetics Juvederm Collection United States			-
Aesthetics Juvederm Collection International			-
Aesthetics Other Aesthetics			-
Aesthetics Other Aesthetics United States			-
Aesthetics Other Aesthetics International			-
Neuroscience Botox Therapeutic			-
Neuroscience Botox Therapeutic United States			-
Neuroscience Botox Therapeutic International			-
Neuroscience Vraylar			-
Neuroscience Vraylar United States			-
Neuroscience Vraylar International			-
Neuroscience Ubrelvy			-
Neuroscience Ubrelvy United States			-
Neuroscience Ubrelvy International			-
Neuroscience Qulipta			-
Neuroscience Qulipta United States			-
Neuroscience Qulipta International			-
Neuroscience Other Neuroscience			-
Neuroscience Other Neuroscience United States			-
Neuroscience Other Neuroscience International			-
Other Key Products Mavyret			-
Other Key Products Mavyret United States			-
Other Key Products Mavyret International			-
Other Key Products Creon United States			-
Neuroscience Vyalev			-
Neuroscience Vyalev United States			-
Neuroscience Vyalev International			-
Oncology Imbruvica			-
Oncology Imbruvica United States			-
Oncology Imbruvica International			-
Oncology Venclexta			-
Oncology Venclexta United States			-
Oncology Venclexta International			-
Oncology Elahere			-
Oncology Elahere United States			-
Oncology Elahere International			-
Oncology Epkinly			-
Oncology Epkinly United States			-
Oncology Epkinly International			-
Oncology Other Oncology United States			-
Other Key Products Linzess			-
Other Key Products Linzess United States			-
Other Key Products Linzess International			-

Company's Cashflow Profitability & Other

Profitability Ratios	Company	Industry	Sector	S&P 500
Free Cash Flow Margin (Q1 MRQ)	23.76 %	-0.01 %	0.21 %	1.5 %
Free Cash Flow Margin (Q1 TTM)	31.81 %	17.24 %	13.98 %	9.11 %
Free Cash Flow Margin 5 Yr. Avg.	-	19.72 %	15.07 %	14.29 %
Net Cash Flow Margin (Q1 MRQ)	27.74 %	0.02 %	-0.02 %	0.14 %
Net Cash Flow Margin (Q1 TTM)	6.71 %	-0.66 %	0.14 %	1.65 %
Net Cash Flow Margin 5 Yr. Avg.	-	4.43 %	3.19 %	5.94 %
Effective Tax Rate (Q1 MRQ)	32.92 %	25.98 %	25.41 %	18.62 %
Effective Tax Rate (Q1 TTM)	39.06 %	21.22 %	22.81 %	19.43 %
Effective Tax Rate 5 Yr. Avg.	13.14 %	15.08 %	20.51 %	19.82 %

Note
To view Detail Information & Trends click on Individual Category. Example: Y / Y Revenue Change (MRQ) or To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table. Example: Industry Sector S&P 500 For explanation of terms visit: Glossary

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.